Who Will Benefit from Charged-Particle Therapy? / Journal of the Korean Cancer Association, 대한암학회지
Cancer Research and Treatment
;
: 621-634, 2021.
Artículo
en Inglés
| WPRIM
| ID: wpr-889742
ABSTRACT
Charged-particle therapy (CPT) such as proton beam therapy (PBT) and carbon-ion radiotherapy (CIRT) exhibit substantial physical and biological advantages compared to conventional photon radiotherapy. As it can reduce the amount of radiation irradiated in the normal organ, CPT has been mainly applied to pediatric cancer and radioresistent tumors in the eloquent area. Although there is a possibility of greater benefits, high set-up cost and dearth of high level of clinical evidence hinder wide applications of CPT. This review aims to present recent clinical results of PBT and CIRT in selected diseases focusing on possible indications of CPT. We also discussed how clinical studies are conducted to increase the number of patients who can benefit from CPT despite its high cost.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Inglés
Revista:
Cancer Research and Treatment
Año:
2021
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS